Pando Bioscience, founded by former Ginkgo engineers, is advancing an enzyme-engineering platform that combines generative AI with an ultra-high-throughput screening approach. The company reports faster cycle times for evaluating thousands of enzyme variants and a feedback loop between wet-lab measurements and model optimization, targeting industrial and pharmaceutical enzyme applications.